Vetoquinol (VETO) Q3 2024 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 TU earnings summary
13 Jun, 2025Executive summary
Nine-month sales reached €398 million, up 1.8% at constant exchange rates and 1.6% on a reported basis compared to the same period last year.
Essential products contributed €241 million, growing 3.9% and representing 61% of total sales, up from 59% a year ago.
Financial highlights
Q3 2024 sales were €134 million, stable at -0.5% at constant exchange rates compared to Q3 2023.
Negative currency impacts totaled €-1 million, mainly from the Americas and Asia Pacific/Rest of World, partially offset by a €1.4 million positive impact in Europe.
Cash position improved during Q3 2024.
Outlook and guidance
Next financial update scheduled for January 30, 2025, with annual sales results.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Vetoquinol
- Net income rose 22% to €30.5M, driven by U.S. and Essentials growth, with improved margins.VETO
H1 2026 - Q1 2026 sales nearly flat at constant exchange rates, with strong U.S. rebound amid currency headwinds.VETOQ1 2026 TU
- Essentials growth and improved profitability drive strong 2025 results despite currency headwinds.VETOH2 2025
- Essential Products drove growth to 64% of sales, offsetting currency and product range headwinds.VETOQ4 2025 TU
- Sales dipped 3.5% YTD, but Essential products grew to 64% of total sales.VETOQ3 2025 TU
- Essentials growth and higher margins offset sales decline, boosting profitability.VETOH1 2025
- Sales up 3.2%, profit margins down as US sales softened and investment rose.VETOH1 2024
- Essential products rose 1.8% as total sales fell 2.3%, led by Asia-Pacific growth.VETOQ1 2025 TU
- Essentials drove 2.2% sales growth and profitability, offsetting U.S. decline.VETOH2 2024